- Home
- TLSI vs VOR Comparison
TLSI vs VOR Comparison
Compare TLSI & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- VOR
- Stock Information
- Founded
- TLSI 2010
- VOR 2015
- Country
- TLSI United States
- VOR United States
- Employees
- TLSI N/A
- VOR N/A
- Industry
- TLSI Medical Specialities
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- TLSI Health Care
- VOR Health Care
- Exchange
- TLSI Nasdaq
- VOR Nasdaq
- Market Cap
- TLSI 244.3M
- VOR 207.1M
- IPO Year
- TLSI N/A
- VOR 2021
- Fundamental
- Price
- TLSI $6.21
- VOR $8.24
- Analyst Decision
- TLSI Strong Buy
- VOR Buy
- Analyst Count
- TLSI 3
- VOR 7
- Target Price
- TLSI $10.67
- VOR $70.43
- AVG Volume (30 Days)
- TLSI 114.0K
- VOR 1.0M
- Earning Date
- TLSI 11-13-2025
- VOR 11-13-2025
- Dividend Yield
- TLSI N/A
- VOR N/A
- EPS Growth
- TLSI N/A
- VOR N/A
- EPS
- TLSI N/A
- VOR N/A
- Revenue
- TLSI $40,207,000.00
- VOR N/A
- Revenue This Year
- TLSI $57.25
- VOR N/A
- Revenue Next Year
- TLSI $54.05
- VOR N/A
- P/E Ratio
- TLSI N/A
- VOR N/A
- Revenue Growth
- TLSI 49.52
- VOR N/A
- 52 Week Low
- TLSI $3.42
- VOR $2.62
- 52 Week High
- TLSI $6.36
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- TLSI 77.66
- VOR 25.11
- Support Level
- TLSI $3.79
- VOR $6.50
- Resistance Level
- TLSI $4.88
- VOR $8.77
- Average True Range (ATR)
- TLSI 0.47
- VOR 1.19
- MACD
- TLSI 0.17
- VOR -0.39
- Stochastic Oscillator
- TLSI 96.84
- VOR 11.15
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.